BUZZ - Aquestive shares surge after reaching US licensing agreement with Eton Pharma for anti-epileptic drug
路透社2026/10/14 12:12October 14 - ** Aquestive Therapeutics (AQST.O) shares rose 4.3% in pre-market trading to $4.87
** The pharmaceutical company said it has (link) granted exclusive U.S. rights to its Libervant medication to Eton Pharmaceuticals ETON.O
** The anti-epileptic drug is expected to launch in April 2027, subject to final approval
** Libervant is a dissolvable diazepam film placed inside the cheek, designed for patients with intermittent seizures; it can be used as an alternative to nasal sprays and rectal administration forms
** The medication was approved by the FDA in April for patients aged 2 to 5 years
** The FDA is reviewing an application to expand usage to children aged 6 to 11; a decision is expected before April
** Shares have fallen 27% so far this year
(To facilitate non-native English speakers, Reuters provides automated translation of its reports in several other languages. As automated translations may contain errors or lack necessary context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for readers' convenience. Reuters accepts no liability for any damage or loss caused by use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ECB’s Dolenc says central bank may not have to do as much if markets tighten
BlackRock CEO Larry Fink warns: AI infrastructure has become the backbone of the US economy, halting data center construction will trigger a recession
BlackRock CEO Larry Fink has issued a rare recession warning, stating that if the United States imposes any form of moratorium on data center construction, the economy will plunge directly into recession. As the midterm elections approach, the construction of AI infrastructure has escalated from a business issue to a political bombshell. Analysts predict that AI capital expenditures could surpass 1 trillion dollars by 2027. Any disruption in policy would trigger a chain reaction impacting the supply chain, job market, and energy industry.
BTC market dominance rises to 60.46%
AI Debt Glut May Be Pushing Up US Government Borrowing Costs, BondCliQ CEO Says
